Cancer Research Career Enhancement and Related Activities

癌症研究职业提升及相关活动

基本信息

项目摘要

PROJECT SUMMARY: CANCER RESEARCH CAREER ENHANCEMENT As the only academic Cancer Center in its four-county catchment area (South Florida), the Sylvester Comprehensive Cancer Center (Sylvester) has a unique responsibility to provide cancer-focused education and training across the career continuum. Sylvester’s Office of Education and Training (OET) coordinates these activities, ensuring they meet and exceed the needs of diverse learners, including students, pre- and postdoctoral trainees, faculty, and healthcare professionals. Kerry L. Burnstein, PhD, Associate Director for Education and Training leads the OET, overseeing the strategic development, coordination, and evaluation of these efforts with assistance from Sylvester leadership and administration, Sylvester’s External Advisory Board, and the Cancer Education Leadership Council, an internal advisory committee comprising University leaders in education, training, and mentoring. They work together to achieve the career enhancement priorities identified in Sylvester’s 2014-2018 Strategic Plan to 1) Build and sustain cancer research careers through stage-specific scientific and professional development; and 2) Provide broad, crosscutting career enhancement and educational programs that facilitate collaborative, interdisciplinary cancer research. While many of the Center’s education and training activities are new, for the past 12 years the Cancer Biology Graduate (CAB) Program has successfully educated dozens of promising graduate students in basic or translational cancer research. Sylvester trainees have been productive and engaged in impactful cancer research; of the 150 publications highlighted by Sylvester’s three Research Programs, trainees were first or second author on 50%. Recently, Sylvester members received five cancer-focused or related T32 training grants, an international U54 grant with Argentina that has a significant education and training component, and an NCI K12 Calabresi award, which will begin enrolling physician scientists in 2019. To extend the impact of these grants, Sylvester will fund an additional trainee for the T32s awards and the K12. Sylvester supports traditional career enhancement activities such as distinguished lecture series, annual retreats, trainee speaking opportunities, and novel educational strategies including a nurse practitioner oncology fellowship and opportunities for medical students to work in medically underserved communities with cancer control experts. Given the unparalleled multicultural and linguistic diversity of the catchment area, Burnstein and the OET work with the University of Miami Clinical and Translational Science Institute leadership and Sylvester’s Associate Director for Population Science and Cancer Disparity to ensure that trainees receive didactic and experiential instruction on how cancer risk and outcome vary across populations, allowing them to consider and possibly incorporate this knowledge into their research design. Together these efforts foster a pipeline of highly motivated healthcare professionals and researchers, uniquely trained to solve the complex cancer-related problems in their communities and beyond.
项目摘要:癌症研究事业的提升 作为其四个县集水区(南佛罗里达州)唯一的学术癌症中心,西尔维斯特 综合癌症中心(西尔维斯特)肩负着提供癌症教育的独特责任 并在整个职业生涯中进行培训。西尔维斯特的教育和培训办公室(OET)协调 这些活动,确保它们满足并超越不同学习者的需求,包括学生、预科和 博士后实习生、教师和医疗保健专业人员。克里·L·伯恩斯坦,博士,副主任 教育和培训领导OET,监督战略发展、协调和评估 这些努力得到了西尔维斯特领导层和行政部门的帮助,西尔维斯特的外部咨询 委员会和癌症教育领导委员会,这是一个内部咨询委员会,由大学 教育、培训和指导方面的领导者。他们共同努力,实现职业提升的优先事项 西尔维斯特2014-2018年战略计划中确定的1)建立和维持癌症研究事业 针对具体阶段的科学和专业发展;以及2)提供广泛的、贯穿各领域的职业发展 以及促进协作、跨学科癌症研究的教育项目。虽然许多人 该中心的教育和培训活动是新的,在过去的12年里,癌症生物学研究生(CAB) 该项目成功地培养了数十名有前途的基础癌症或转化性癌症研究生 研究。西尔维斯特受训人员一直在从事富有成效的癌症研究;在150名受训人员中 由西尔维斯特的三个研究项目重点介绍的出版物中,受训人员以50%的比例成为第一或第二作者。 最近,西尔维斯特成员获得了五项专注于癌症或相关的T32培训资助,一项国际U54 与阿根廷合作,拥有重要的教育和培训内容,并获得NCI K12卡拉布雷西奖, 它将于2019年开始招收内科科学家。为了扩大这些赠款的影响,西尔维斯特将资助 T32大奖和K12大奖的额外实习生。西尔维斯特支持传统的职业提升 杰出系列讲座、年度静修、实习生演讲机会和小说等活动 教育策略,包括为医科学生提供护士执业医师肿瘤学奖学金和机会 与癌症控制专家一起在医疗服务不足的社区工作。考虑到无与伦比的多元文化 和语言的多样性,Burnstein和OET与迈阿密临床大学合作 和翻译科学研究所的领导和西尔维斯特的人口科学和 癌症差异,以确保受训者接受关于癌症风险和癌症风险的说教和经验指导 结果因人群而异,允许他们考虑并可能将这一知识纳入他们的 研究设计。这些努力共同培养了一批充满干劲的医疗保健专业人员,并 研究人员,受过独特的培训,能够解决他们所在社区内外与癌症相关的复杂问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kerry L Burnstein其他文献

Kerry L Burnstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kerry L Burnstein', 18)}}的其他基金

Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10814125
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10153099
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10341159
  • 财政年份:
    2021
  • 资助金额:
    $ 5.13万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10190856
  • 财政年份:
    2019
  • 资助金额:
    $ 5.13万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10670835
  • 财政年份:
    2019
  • 资助金额:
    $ 5.13万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    9789581
  • 财政年份:
    2019
  • 资助金额:
    $ 5.13万
  • 项目类别:
A Novel Drug Target for Aggressive Prostate Cancer
侵袭性前列腺癌的新药物靶点
  • 批准号:
    10083680
  • 财政年份:
    2018
  • 资助金额:
    $ 5.13万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8056479
  • 财政年份:
    2009
  • 资助金额:
    $ 5.13万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8459533
  • 财政年份:
    2009
  • 资助金额:
    $ 5.13万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8257572
  • 财政年份:
    2009
  • 资助金额:
    $ 5.13万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 5.13万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 5.13万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 5.13万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 5.13万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 5.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了